EP2830711A4 - Procédés et compositions à l'aide de fgf-9 pour améliorer la néovascularisation et la régénération - Google Patents

Procédés et compositions à l'aide de fgf-9 pour améliorer la néovascularisation et la régénération

Info

Publication number
EP2830711A4
EP2830711A4 EP13770266.8A EP13770266A EP2830711A4 EP 2830711 A4 EP2830711 A4 EP 2830711A4 EP 13770266 A EP13770266 A EP 13770266A EP 2830711 A4 EP2830711 A4 EP 2830711A4
Authority
EP
European Patent Office
Prior art keywords
enchance
neovascularization
fgf
regeneration
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13770266.8A
Other languages
German (de)
English (en)
Other versions
EP2830711A1 (fr
Inventor
Dinendar Singla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Central Florida Research Foundation Inc UCFRF
Original Assignee
University of Central Florida Research Foundation Inc UCFRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Central Florida Research Foundation Inc UCFRF filed Critical University of Central Florida Research Foundation Inc UCFRF
Publication of EP2830711A1 publication Critical patent/EP2830711A1/fr
Publication of EP2830711A4 publication Critical patent/EP2830711A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
EP13770266.8A 2012-03-30 2013-03-09 Procédés et compositions à l'aide de fgf-9 pour améliorer la néovascularisation et la régénération Withdrawn EP2830711A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261618280P 2012-03-30 2012-03-30
PCT/US2013/030082 WO2013148122A1 (fr) 2012-03-30 2013-03-09 Procédés et compositions à l'aide de fgf-9 pour améliorer la néovascularisation et la régénération

Publications (2)

Publication Number Publication Date
EP2830711A1 EP2830711A1 (fr) 2015-02-04
EP2830711A4 true EP2830711A4 (fr) 2015-08-26

Family

ID=49261002

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13770266.8A Withdrawn EP2830711A4 (fr) 2012-03-30 2013-03-09 Procédés et compositions à l'aide de fgf-9 pour améliorer la néovascularisation et la régénération

Country Status (3)

Country Link
EP (1) EP2830711A4 (fr)
CA (1) CA2869169A1 (fr)
WO (1) WO2013148122A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015164800A2 (fr) * 2014-04-24 2015-10-29 University Of Central Florida Research Foundation, Inc. Compositions et procédés permettant de moduler la polarisation des monocytes
CN104587103B (zh) * 2014-12-04 2018-10-19 南京中医药大学 一种治疗出血性中风中药挥发油提取物成分群的提取方法及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010031190A1 (fr) * 2008-09-22 2010-03-25 UNIVERSITé LAVAL Milieu de culture pour des myoblastes, leurs précurseurs et leurs dérivés

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7764995B2 (en) * 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
JP2008513542A (ja) * 2004-09-22 2008-05-01 ジェンザイム・コーポレイション 免疫抑制剤の腎毒性を制限するためのＴＧＦ−βアンタゴニストの使用
US20070065415A1 (en) * 2005-09-16 2007-03-22 Kleinsek Donald A Compositions and methods for the augmentation and repair of defects in tissue
CN102186483A (zh) * 2008-08-11 2011-09-14 德克萨斯大学系统董事会 促进血管完整性的微rna及其用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010031190A1 (fr) * 2008-09-22 2010-03-25 UNIVERSITé LAVAL Milieu de culture pour des myoblastes, leurs précurseurs et leurs dérivés

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BINBIN YAN ET AL: "Transplanted Induced Pluripotent Stem Cells Improve Cardiac Function and Induce Neovascularization in the Infarcted Hearts of db/db Mice", MOLECULAR PHARMACEUTICS, vol. 8, no. 5, 3 October 2011 (2011-10-03), pages 1602 - 1610, XP055202239, ISSN: 1543-8384, DOI: 10.1021/mp2003576 *
See also references of WO2013148122A1 *

Also Published As

Publication number Publication date
EP2830711A1 (fr) 2015-02-04
CA2869169A1 (fr) 2013-10-03
WO2013148122A1 (fr) 2013-10-03

Similar Documents

Publication Publication Date Title
IL285985B1 (en) Therapeutic nuclease preparations and methods
IL237156B (en) Microcapsule preparation and methods
IL252566B (en) Pharmacy preparations and methods
EP2836212A4 (fr) Nouvelles compositions et nouveaux procédés
IL235875A0 (en) An anti-mucus preparation based on xylitol and methods and preparations related thereto
EP2717926A4 (fr) Compositions et procédés pour prévenir et traiter des biofilms
EP2849800A4 (fr) Compositions et méthodes pour moduler l'expression de bdnf
EP2884984A4 (fr) Compositions et procédés thérapeutiques
HK1214961A1 (zh) 粘多醣病 型的鞘內注射治療的方法和組合物
HK1206970A1 (en) Antigenic compositions and methods
EP2806894A4 (fr) Procédés et compositions pour agents thérapeutiques
GB201315350D0 (en) Methods and compositions
EP2931324A4 (fr) Compositions et procédés de régénération tissulaire
GB201315347D0 (en) Methods and compositions
EP2895186A4 (fr) Compositions thérapeutiques et méthodes associées
EP2870238A4 (fr) Compositions et procédés associés à des vaccins viraux
EP2830711A4 (fr) Procédés et compositions à l'aide de fgf-9 pour améliorer la néovascularisation et la régénération
HK1231520A1 (zh) 改進的基質穩定性組合物和方法
EP2934092A4 (fr) Compositions et procédés pour induire un tropisme préférentiel des racines
GB201208315D0 (en) Pharmaceutical methods and compositions
HUE032878T2 (hu) Bõrvédõ és bõrkiegyensúlyozó készítmény
GB201200637D0 (en) Improvements in and relating to compositions
GB201205173D0 (en) Methods and compositions relating to neurocognitive disorders
GB201202940D0 (en) Improvements in or relating to dentures

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20141029

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20150727

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/10 20060101AFI20150721BHEP

Ipc: A61K 38/18 20060101ALI20150721BHEP

Ipc: A61K 35/545 20150101ALI20150721BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160224